文献速递糖尿病肥胖与代谢综合征

骨骼肌TET3通过去稳定化PGC-1α促进胰岛素抵抗

Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1α.
PubMed 文献 · Diabetologia · 2024-01-13

研究在2型糖尿病患者及高脂饮食或ob/ob肥胖糖尿病小鼠的骨骼肌中发现TET3表达升高,肌肉特异性Tet3敲除小鼠糖耐量、胰岛素敏感性改善且对高脂饮食诱导的胰岛素抵抗更具抵抗力;TET3与PGC-1α形成复合物干扰其磷酸化导致其去稳定化,提示TET3可能作为代谢综合征的潜在治疗靶点。

要点

  • 2型糖尿病患者及高脂饮食、ob/ob小鼠骨骼肌中TET3表达升高
  • 肌肉特异性Tet3敲除小鼠糖耐量、胰岛素敏感性增强,对高脂饮食诱导的胰岛素抵抗更具抵抗力
  • TET3与PGC-1α形成复合物并干扰其磷酸化,导致PGC-1α去稳定化

核心结论

  • TET3在骨骼肌胰岛素敏感性调节中起重要作用,TET3可能作为代谢综合征的潜在治疗靶点。

研究设计与样本

  • 分析2型糖尿病患者与非糖尿病者及高脂饮食诱导或ob/ob肥胖/糖尿病小鼠骨骼肌中TET表达水平。
  • 构建肌肉特异性Tet3敲除(mKD)小鼠研究TET3在肌肉胰岛素敏感性中的作用。
  • 对野生型(WT)与mKD小鼠肌肉组织进行RNA-seq全基因组表达谱分析。
  • 利用肌肉组织和体外来源的肌管研究PGC-1α与TET3表达水平的相关性。
  • 采用体外实验分析PGC-1α磷酸化与降解。

主要发现

  • 与健康对照相比,2型糖尿病患者及高脂饮食喂养和ob/ob小鼠骨骼肌中TET3表达升高。
  • mKD小鼠表现出糖耐量增强、胰岛素敏感性增强及对高脂饮食诱导的胰岛素抵抗更具抵抗力。
  • RNA-seq通路分析显示「线粒体功能」和「PPARα通路」是TET3调控的主要生物学过程之一。
  • mKD小鼠肌肉中PGC-1α水平较WT小鼠高约25%,高脂饮食喂养或ob/ob小鼠肌肉中PGC-1α蛋白水平较各自对照低约25-60%。
  • 在人及小鼠肌管中,TET3敲低后PGC-1α水平升高,有助于改善线粒体呼吸和胰岛素敏感性。

临床怎么用

  • 原文结论提示TET3可能作为代谢综合征的潜在治疗靶点,原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM/HYPOTHESIS: The peroxisome proliferator-activated receptor-γ coactivator α (PGC-1α) plays a critical role in the maintenance of glucose, lipid and energy homeostasis by orchestrating metabolic programs in multiple tissues in response to environmental cues. In skeletal muscles, PGC-1α dysregulation has been associated with insulin resistance and type 2 diabetes but the underlying mechanisms have remained elusive. This research aims to understand the role of TET3, a member of the ten-eleven translocation (TET) family dioxygenases, in PGC-1α dysregulation in skeletal muscles in obesity and diabetes. METHODS: TET expression levels in skeletal muscles were analysed in humans with or without type 2 diabetes, as well as in mouse models of high-fat diet (HFD)-induced or genetically induced (ob/ob) obesity/diabetes. Muscle-specific Tet3 knockout (mKD) mice were generated to study TET3's role in muscle insulin sensitivity. Genome-wide expression profiling (RNA-seq) of muscle tissues from wild-type (WT) and mKD mice was performed to mine deeper insights into TET3-mediated regulation of muscle insulin sensitivity. The correlation between PGC-1α and TET3 expression levels was investigated using muscle tissues and in vitro-derived myotubes. PGC-1α phosphorylation and degradation were analysed using in vitro assays. RESULTS: TET3 expression was elevated in skeletal muscles of humans with type 2 diabetes and in HFD-fed and ob/ob mice compared with healthy controls. mKD mice exhibited enhanced glucose tolerance, insulin sensitivity and resilience to HFD-induced insulin resistance. Pathway analysis of RNA-seq identified 'Mitochondrial Function' and 'PPARα Pathway' to be among the top biological processes regulated by TET3. We observed higher PGC-1α levels (~25%) in muscles of mKD mice vs WT mice, and lower PGC-1α protein levels (~25-60%) in HFD-fed or ob/ob mice compared with their control counterparts. In human and murine myotubes, increased PGC-1α levels following TET3 knockdown contributed to improved mitochondrial respiration and insulin sensitivity. TET3 formed a complex with PGC-1α and interfered with its phosphorylation, leading to its destabilisation. CONCLUSIONS/INTERPRETATION: Our results demonstrate an essential role for TET3 in the regulation of skeletal muscle insulin sensitivity and suggest that TET3 may be used as a potential therapeutic target for the metabolic syndrome. DATA AVAILABILITY: Sequences are available from the Gene Expression Omnibus ( https://www.ncbi.nlm.nih.gov/geo/ ) with accession number of GSE224042.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Liu B, Xie D, Huang X, et al. Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1α. Diabetologia. 2024. PMID: 38216792. doi:10.1007/s00125-023-06073-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。